Stocktoria
TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 1951-01-01
TEVA PHARMACEUTICAL INDUSTRIES LTD statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 51.8% | 48.7% | 48.2% | 46.7% | 47.8% |
| Operating margin | 12.5% | -1.8% | 2.7% | -14.7% | 10.8% |
| Net margin | 8.2% | -9.9% | -3.5% | -16.4% | 2.6% |
| FCF margin | — | — | — | 7.0% | 1.5% |
| Return on assets | 3.5% | -4.2% | -1.3% | -5.6% | 0.9% |
| Return on equity | 17.8% | -30.5% | -6.9% | -28.4% | 3.7% |
| Current ratio | 1.04 | 0.98 | 1.02 | 1.05 | 1.14 |
| Revenue growth | 4.3% | 4.4% | 6.2% | -6.0% | -4.7% |
Source: SEC EDGAR filings · CIK 0000818686 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.